MetLife Investment Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$191K Buy
92,426
+37,738
+69% +$78.1K ﹤0.01% 2222
2025
Q1
$120K Sell
54,688
-18,002
-25% -$39.6K ﹤0.01% 2443
2024
Q4
$111K Buy
72,690
+635
+0.9% +$972 ﹤0.01% 2570
2024
Q3
$143K Hold
72,055
﹤0.01% 2459
2024
Q2
$252K Buy
72,055
+31,944
+80% +$112K ﹤0.01% 2104
2024
Q1
$111K Sell
40,111
-13,453
-25% -$37.3K ﹤0.01% 2483
2023
Q4
$91.1K Hold
53,564
﹤0.01% 2645
2023
Q3
$55.2K Hold
53,564
﹤0.01% 2816
2023
Q2
$62.1K Hold
53,564
﹤0.01% 2878
2023
Q1
$80.9K Hold
53,564
﹤0.01% 2634
2022
Q4
$134K Hold
53,564
﹤0.01% 2470
2022
Q3
$226K Hold
53,564
﹤0.01% 2217
2022
Q2
$149K Hold
53,564
﹤0.01% 2498
2022
Q1
$306K Buy
53,564
+20,791
+63% +$119K ﹤0.01% 2079
2021
Q4
$299K Hold
32,773
﹤0.01% 1818
2021
Q3
$350K Hold
32,773
﹤0.01% 1737
2021
Q2
$509K Hold
32,773
﹤0.01% 1557
2021
Q1
$531K Sell
32,773
-6,301
-16% -$102K ﹤0.01% 1492
2020
Q4
$827K Hold
39,074
0.01% 1218
2020
Q3
$579K Hold
39,074
0.01% 1297
2020
Q2
$575K Buy
39,074
+2,530
+7% +$37.2K 0.01% 1303
2020
Q1
$429K Hold
36,544
0.01% 1294
2019
Q4
$859K Buy
36,544
+2,703
+8% +$63.5K 0.01% 1167
2019
Q3
$626K Hold
33,841
0.01% 1300
2019
Q2
$629K Buy
33,841
+4,475
+15% +$83.2K 0.01% 1347
2019
Q1
$718K Hold
29,366
0.01% 1234
2018
Q4
$762K Hold
29,366
0.01% 1133
2018
Q3
$929K Hold
29,366
0.01% 1166
2018
Q2
$1.14M Buy
29,366
+4,394
+18% +$171K 0.01% 969
2018
Q1
$689K Buy
24,972
+2,926
+13% +$80.7K 0.01% 1177
2017
Q4
$399K Buy
+22,046
New +$399K ﹤0.01% 1531